| Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Sandler Alan B. | Chief Development Officer | Sep 29 '26 | Option Exercise | 58.84 | 6,000 | 353,040 | 58,868 | Oct 01 06:00 PM | |
| Sandler Alan B. | Chief Development Officer | Sep 29 '26 | Sale | 202.14 | 6,309 | 1,275,294 | 52,559 | Oct 01 06:00 PM | |
| ALAN SANDLER | Officer | Sep 29 '26 | Proposed Sale | 201.74 | 6,309 | 1,272,778 | Sep 29 04:24 PM | ||
| Sandler Alan B. | Chief Development Officer | Sep 16 '26 | Sale | 199.24 | 341 | 67,941 | 52,868 | Sep 18 06:06 PM | |
| Sandler Alan B | Officer | Sep 15 '26 | Proposed Sale | 203.77 | 331 | 67,448 | Sep 15 06:11 PM | ||
| Sandler Alan B. | Head of Global Dev., Oncology | Apr 01 '22 | Option Exercise | 0.00 | 1,060 | 0 | 28,985 | Apr 05 04:05 PM | |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite